scholarly journals Factors associated with adherence in physical exercise and sport in Outpatients with Major Depressive Disorder

Author(s):  
Fernanda Castro Monteiro ◽  
Felipe Barreto Schuch ◽  
Andrea Camaz Deslandes ◽  
Bruno Paz Mosqueiro ◽  
Marco Caldieraro ◽  
...  
Author(s):  
Susana Sousa ◽  
Constança Paúl ◽  
Laetitia Teixeira

Major depressive disorder (MDD) is one of the most common mental disorders in older people. There are several biological, psychological, and social factors associated with this disorder. This study aimed to describe the depressive state to identify the associated factors and potential predictors of MDD in a population of community-dwelling older people with probable MDD. The sample consisted of 378 participants with probable dementia, with 47.3% of them presenting MDD. The factors that were found to be associated with MDD were sex, living status, mobility, and nutritional status. Knowing the factors that can predict a condition such as MDD is extremely important, both for prevention and for the customization of interventions.


2018 ◽  
Vol 240 ◽  
pp. 48-56 ◽  
Author(s):  
Nágila Soares Xavier Oenning ◽  
Patrícia Klarmann Ziegelmann ◽  
Bárbara Niegia Garcia de Goulart ◽  
Isabelle Niedhammer

2019 ◽  
Vol 251 ◽  
pp. 263-269 ◽  
Author(s):  
Alejandro Porras-Segovia ◽  
Margarita Rivera ◽  
Esther Molina ◽  
David López-Chaves ◽  
Blanca Gutiérrez ◽  
...  

2011 ◽  
Vol 42 (2) ◽  
pp. 327-334 ◽  
Author(s):  
J. L. Wang ◽  
S. B. Patten ◽  
S. Currie ◽  
J. Sareen ◽  
N. Schmitz

BackgroundExamining predictors of the outcomes of major depressive disorder (MDD) is important for clinical practice and population health. There are few population-based longitudinal studies on this topic. The objectives of this study were to (1) estimate the proportions of persistent and recurrent MDD among those with MDD over 1 year, and (2) identify demographic, socio-economic, workplace psychosocial and clinical factors associated with the outcomes.MethodFrom a population-based longitudinal study of the working population, participants with a lifetime diagnosis of MDD were selected (n=834). They were classified into two groups: those with and those without current MDD. The proportions of 1-year persistence and recurrence of MDD were estimated. MDD was assessed by the World Health Organization (WHO) Composite International Diagnostic Interview, CIDI-Auto 2.1, by telephone.ResultsThe proportions of persistent and recurrent MDD in 1 year were 38.5% [95% confidence interval (CI) 31.1–46.5] and 13.3% (95% CI 10.2–17.1) respectively. Long working hours, negative thinking and having co-morbid social phobia were predictive of persistence of MDD. Perceived work–family conflict, the severity of a major depressive episode and symptoms of depressed mood were significantly associated with the recurrence of MDD.ConclusionsClinical and psychosocial factors are important in the prognosis of MDD. The factors associated with persistence and recurrence of MDD may be different. More large longitudinal studies on this topic are needed so that clinicians may predict potential outcomes based on the clinical profile and provide interventions accordingly. They may also take clinical action to change relevant psychosocial factors to minimize the chance of persistence and/or recurrence of MDD.


Cephalalgia ◽  
2015 ◽  
Vol 36 (5) ◽  
pp. 493-498 ◽  
Author(s):  
Jong-Geun Seo ◽  
Sung-Pa Park

Background Almost one-third of patients with migraine do not adequately respond to triptans. We examined factors contributing to frovatriptan response in patients with migraine. Methods We enrolled new patients with migraine who consecutively visited our headache clinic. Eligible patients were instructed to take 2.5 mg of frovatriptan as soon as possible after migraine attack. The responsiveness was determined by whether headache was relieved or absent within 4 hours after the intake of frovatriptan. We assessed frovatriptan to be efficacious when headache responded to its administration in at least one of two successive migraine attacks and inefficacious when headache was not relieved in either attack. We included demographic, clinical and psychiatric variables in the analysis of factors associated with frovatriptan response. Results Of 128 eligible patients, 28 (21.9%) experienced frovatriptan inefficacy. In 24 patients with current major depressive disorder, 12 (50.0%) had frovatriptan inefficacy. Only current major depressive disorder was identified as a risk factor for inefficacy (odds ratio = 5.500, 95% confidence interval 2.103–14.382, p = 0.001). Conclusions Depression may be a risk factor of frovatriptan inefficacy in patients with migraine, even though half of patients with major depressive disorder respond to frovatriptan.


2014 ◽  
Vol 73 (Suppl 2) ◽  
pp. 416.3-417 ◽  
Author(s):  
T.A. Lisitsyna ◽  
D. Veltishchev ◽  
A. Gerasimov ◽  
O. Seravina ◽  
O. Kovalevskaya ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document